V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010613 | 270013030 | null | 63.4 | Palliative (P) | null | 2013-12-17 | Cetuximab 7 day (Cycle 1) | null | null | 270005126 | CAPECITABINE + IRINOTECAN |
| 270010614 | 270006245 | 1.82 | null | Palliative (P) | 2017-06-27 | 2017-06-28 | Bevacizumab + Capecitabine | N | N | 270005145 | CETUXIMAB |
| 270010615 | 270006246 | 1.81 | 70.6 | Curative (C) | 2017-05-27 | 2017-06-10 | R ABVD | N | N | 270005171 | ETOPOSIDE |
| 270010616 | 270006247 | null | 78.75 | Palliative (P) | 2018-05-09 | 2018-05-17 | CARBOPLATIN + RT | N | N | 270005186 | CETUXIMAB + RT |
| 270010617 | 270006247 | null | 101 | Palliative (P) | 2017-09-16 | 2017-09-23 | CAP + RT | N | N | 270005186 | FLUOROURACIL + RT |
| 270010618 | 270006248 | null | null | null | null | 2016-07-21 | CVP R | null | null | 270005353 | CARBOPLATIN + RT |
| 270010619 | 270006249 | null | 65 | Not known (9) | null | 2018-03-21 | FLUOROURACIL + MITOMYCIN | null | null | 270005477 | CARBOPLATIN + RT |
| 270010620 | 270006249 | null | 63.8 | Neo-adjuvant (N) | 2015-08-31 | 2016-06-11 | CAPECITABINE + IRINOTECAN | null | null | 270005477 | CETUXIMAB + RT |
| 270010621 | 270016128 | 1.8 | 105 | Curative (C) | 2017-11-04 | 2017-11-15 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270005582 | ESHAP |
| 270010622 | 270016128 | null | null | Palliative (P) | 2017-11-01 | 2017-11-05 | Azacitidine | 02 | N | 270005582 | CETUXIMAB + RT |
| 270010623 | 270006250 | 1.6 | null | Curative (C) | null | 2016-12-29 | CHOP | null | null | 270005776 | VINBLASTINE |
| 270010624 | 270006251 | 1.55 | 82.7 | Curative (C) | 2013-12-27 | 2013-12-27 | Carboplatin AUC 6 - 10 | N | N | 270005860 | CETUXIMAB + RT |
| 270010625 | 270006252 | 1.5 | 68 | Palliative (P) | 2014-04-24 | 2014-05-02 | CETUXIMAB + RT | N | N | 270005862 | CARBOPLATIN + RT |
| 270010626 | 270006253 | 1.6 | 63.5 | Curative (C) | 2013-02-10 | 2014-07-14 | Cetuximab + Radiotherapy Load | N | N | 270005990 | CETUXIMAB + RT |
| 270010627 | 270006254 | null | 84.1 | Disease modification (D) | 2018-03-02 | 2018-03-02 | ECHELON 1 TRIAL | N | N | 270005991 | RITUXIMAB |
| 270010628 | 270006255 | 1.6 | 0 | Curative (C) | 2018-09-26 | 2018-10-11 | IBRUTINIB | N | N | 270006017 | CYTARABINE |
| 270010629 | 270006255 | 1.5 | 61 | Curative (C) | 2015-05-20 | 2015-05-22 | Cetuximab + Radiotherapy Load | N | N | 270006017 | CETUXIMAB + RT |
| 270010630 | 270006256 | 1.7 | 71 | Palliative (P) | 2017-04-09 | 2018-01-30 | CARBOPLATIN | N | N | 270006156 | CAPECITABINE + IRINOTECAN |
| 270010631 | 270013034 | 1.73 | 91.3 | Adjuvant (A) | 2013-08-06 | 2013-08-06 | Bevacizumab + Oxaliplatin +MdG | N | N | 270006187 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010632 | 270006257 | 1.69 | 93.3 | Curative (C) | 2018-01-08 | 2018-01-14 | Folfirinox | N | N | 270006274 | CETUXIMAB + RT |
| 270010633 | 270006258 | 1.59 | 68.9 | Palliative (P) | 2017-01-23 | 2017-01-27 | SCOT TRIAL | 02 | N | 270006292 | CARBOPLATIN |
| 270010634 | 270006259 | 1.78 | 69.4 | null | 2015-11-23 | 2015-11-30 | Carboplatin + Pemetrexed | N | N | 270006324 | CETUXIMAB + RT |
| 270010635 | 270006260 | 1.81 | 69.5 | Curative (C) | 2016-10-06 | 2016-10-08 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 2 | N | 270006353 | MITOMYCIN INTRAVESICULAR |
| 270010636 | 270006261 | 1.57 | 94.7 | Curative (C) | 2017-03-09 | 2017-03-10 | Cetuximab + Radiotherapy Load | N | N | 270006407 | CETUXIMAB + RT |
| 270010637 | 270006262 | 1.68 | null | null | 2017-02-22 | 2017-03-14 | Pazopanib | N | N | 270006506 | ENZALUTAMIDE |
| 270010638 | 270006263 | 1.68 | 66.3 | Palliative (P) | 2016-02-24 | 2016-03-15 | Carboplatin + Vinorelbine Oral | N | Y | 270006621 | BEVACIZUMAB |
| 270010639 | 270013035 | null | null | Neo-adjuvant (N) | 2015-10-10 | 2015-11-06 | Cetuximab + Radiotherapy Load | 02 | N | 270006622 | CETUXIMAB + RT |
| 270010640 | 270013035 | 1.6 | 48.7 | Neo-adjuvant (N) | 2014-11-22 | 2014-12-13 | CETUXIMAB + RT | 2 | null | 270006622 | CISPLATIN + VINORELBINE |
| 270010641 | 270013035 | 1.8 | 88.7 | Palliative (P) | 2014-09-06 | 2014-09-08 | Cytarabine Low Dose | 02 | N | 270006622 | CISPLATIN + ETOPOSIDE |
| 270010642 | 270006264 | 1.73 | 42 | Palliative (P) | 2017-09-14 | 2017-10-05 | Cetuximab 7 day (>Cycle 2) | 2 | N | 270006769 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270010643 | 270006265 | 1.7 | null | Curative (C) | null | 2016-07-30 | SCOT TRIAL | N | N | 270006854 | CARBOPLATIN + ETOPOSIDE |
| 270010644 | 270006266 | null | 55.6 | Adjuvant (A) | 2017-08-02 | 2017-08-12 | Carboplatin + Etoposide IV 3 day | 2 | N | 270006883 | FLUOROURACIL + MITOMYCIN + RT |
| 270010645 | 270006266 | 1.7 | 82.35 | Palliative (P) | 2017-02-27 | 2017-03-13 | CETUXIMAB + RT | N | Y | 270006883 | CETUXIMAB + RT |
| 270010646 | 270006267 | 1.52 | 62 | Neo-adjuvant (N) | 2015-05-06 | 2015-06-03 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270007091 | CETUXIMAB |
| 270010647 | 270006268 | 1.71 | 64.5 | Palliative (P) | 2016-05-16 | 2016-05-17 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270007141 | CARBOPLATIN + VINORELBINE |
| 270010648 | 270006269 | 1.65 | 43.5 | Palliative (P) | 2017-07-10 | 2017-07-21 | Bevacizumab + Irinotecan + MdG | 2 | N | 270007149 | CAPECITABINE + CARBOPLATIN |
| 270010649 | 270006270 | 1.65 | 67.2 | Palliative (P) | 2017-01-16 | 2017-02-18 | FOXTROT TRIAL | N | N | 270007211 | CAPECITABINE + MITOMYCIN + RT |
| 270010650 | 270006271 | 1.61 | 96 | Palliative (P) | 2017-02-04 | 2017-02-10 | CAP + RT | N | N | 270007266 | CISPLATIN + FLUOROURACIL + RT |
| 270010651 | 270006272 | null | null | Adjuvant (A) | 2016-06-07 | 2016-07-01 | ESHAP | N | N | 270007413 | CETUXIMAB + RT |
| 270010652 | 270006273 | 1.85 | 75.3 | Adjuvant (A) | 2017-01-21 | 2017-02-03 | Cisplatin + Vinorelbine (IV) | 02 | N | 270007433 | CARBOPLATIN + ETOPOSIDE |
| 270010653 | 270006273 | null | null | Curative (C) | 2018-01-02 | 2018-01-08 | CVP R | 2 | N | 270007433 | NOT MATCHED |
| 270010654 | 270016130 | 1.6 | 71.9 | null | 2014-03-22 | 2014-03-28 | GemCarbo Days 1+8 | N | N | 270007796 | CISPLATIN + ETOPOSIDE |
| 270010655 | 270016130 | 1.62 | 69 | Palliative (P) | 2016-12-29 | 2016-12-29 | CARBOPLATIN + RT | 02 | N | 270007796 | GEMCITABINE |
| 270010656 | 270006274 | 1.76 | 62.2 | Palliative (P) | 2014-12-11 | 2014-12-21 | PMitCEBO | Y | N | 270008067 | RITUXIMAB |
| 270010657 | 270006275 | 1.6 | 95 | Curative (C) | 2017-08-28 | 2017-09-17 | Cisplatin + Etoposide (3 day) | 2 | Y | 270008070 | CISPLATIN + ETOPOSIDE |
| 270010658 | 270006276 | 1.73 | 75.5 | Curative (C) | 2019-02-14 | 2019-02-14 | Pemetrexed | N | N | 270008125 | CARBOPLATIN + ETOPOSIDE |
| 270010659 | 270006277 | 1.79 | 87.3 | Curative (C) | 2018-07-14 | 2018-07-25 | Bortezomib +/- Dexamethasone | N | N | 270008140 | MITOMYCIN INTRAVESICULAR |
| 270010660 | 270006277 | 1.72 | 47.4 | Palliative (P) | 2014-08-29 | 2014-09-12 | CETUXIMAB | N | Y | 270008140 | CETUXIMAB + RT |
| 270010661 | 270016131 | 1.77 | 74.6 | Palliative (P) | 2019-04-26 | 2019-04-26 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 270008261 | CARBOPLATIN + ETOPOSIDE |
| 270010662 | 270016131 | 1.6 | 75 | Curative (C) | 2013-12-10 | 2013-12-13 | Hydroxycarbamide | N | N | 270008261 | IMATINIB |